Genomic Deletions Explain the Generation of Alternative BRAF Isoforms Conferring Resistance to MAPK Inhibitors in Melanoma

Using different in vitro models of alternative BRAF mRNA isoforms (altBRAF)-mediated melanoma resistance, researchers demonstrated the production of altBRAFs exclusively from the BRAF V600E allele, correlating with corresponding genomic deletions.